Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy

By Sa-Filho D.J.   Costa L.J.   de Oliveira C.F.   Guimaraes A.P.C.   Accetturi C.V.A.   Tanuri A.   Diaz R.S.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 186-202

Elsevier

Access to resources Recommend Favorite

Progressive Stroke in an HIV-1-Positive Patient under Protease Inhibitors

By  

European Neurology, Vol. 44, Iss. 4, 2000-11 ,pp. : 252-254

Karger

Access to resources Recommend Favorite

Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance

By Babrzadeh Farbod   Varghese Vici   Pacold Mary   Liu Tommy F.   Nyrén Pål   Schiffer Celia   Fessel W. Jeffrey   Shafer Robert W.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 414-418

Oxford University Press

Access to resources Recommend Favorite

Severe Impairment of Endothelial Function with the HIV-1 Protease Inhibitor Indinavir is not Mediated by Insulin Resistance in Healthy Subjects

By Dubé Michael   Gorski Jude   Shen Changyu  

Cardiovascular Toxicology, Vol. 8, Iss. 1, 2008-03 ,pp. : 15-22

Humana Press, Inc

Access to resources Recommend Favorite

Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients

By  

Current HIV Research, Vol. 7, Iss. 4, 2009-07 ,pp. : 425-433

Bentham Science Publishers

Access to resources Recommend Favorite